Stay updated on AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Sign up to get notified when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.

Latest updates to the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing the previous revision. The government funding status notice and the Revision: v3.4.1 notice were removed.SummaryDifference0.2%

- Check21 days agoChange DetectedAdded a system-wide notice about a lapse in government funding and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check28 days agoChange DetectedAdded a glossary toggle, updated the label to 'Last Update Submitted that Met QC Criteria', corrected capitalization to 'No FEAR Act Data', and introduced 'Revision: v3.4.0'.SummaryDifference0.1%

- Check35 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to study details or navigation.SummaryDifference0.0%

- Check63 days agoChange DetectedThe page now includes a consolidated Locations section listing participating states (Alabama through Wisconsin). The HHS Vulnerability Disclosure section was removed.SummaryDifference2%

- Check91 days agoChange DetectedAdded note that publications are automatically filled in from PubMed. Revision updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration
Enter your email address, and we'll notify you when there's something new on the AREDS2 Clinical Trial: Supplement to Prevent Age-Related Macular Degeneration page.